Phenotype and Genotype of Pancreatic Cancer Cell Lines

Tumor angiogenesis: therapeutic implications

Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187 · see citing works

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885 · see citing works

Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses

Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969 · see citing works

THE CHEMOTACTIC EFFECT OF MIXTURES OF ANTIBODY AND ANTIGEN ON POLYMORPHONUCLEAR LEUCOCYTES

BOYDEN, S. V. (1962) · The Journal of Experimental Medicine · doi:10.1084/jem.115.3.453 · Cited by 2,732 · see citing works

<i>DPC4</i> , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1

Hahn, S. A., Schutte, M., Shamsul Hoque, A. T. M., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., et al. (1996) · Science · doi:10.1126/science.271.5247.350 · Cited by 2,337 · see citing works

Interleukin-8 as a macrophage-derived mediator of angiogenesis

Koch, A. E., Polverini, P. J., Kunkel, S. L., Harlow, L. A., DiPietro, L. A., Elner, V. M., Elner, S. G., & Strieter, R. M. (1992) · Science · doi:10.1126/science.1281554 · Cited by 2,135 · see citing works

RAS oncogenes: the first 30 years

Malumbres, M., & Barbacid, M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1097 · Cited by 1,902 · see citing works

A rapid in vitro assay for quantitating the invasive potential of tumor cells.

Albini, A., Iwamoto, Y., Hk, K., Gr, M., Aaronson, S. A., Jm, K., & McEwan, R. N. (1987) · PubMed · Cited by 1,769 · see citing works

The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics

Sambuy, Y., Angelis, I. D., Ranaldi, G., Scarino, M. L., Stammati, A. P., & Zucco, F. (2005) · Cell Biology and Toxicology · doi:10.1007/s10565-005-0085-6 · Cited by 1,494 · see citing works

Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential

Tsujii, M., Kawano, S., & DuBois, R. N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3336 · Cited by 1,398 · see citing works

Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.

Masferrer, J. L., Leahy, K. M., Koki, A. T., Zweifel, B. S., Settle, S. L., Woerner, B. M., Edwards, D. A., Flickinger, A. G., Moore, R. J., & Seibert, K. (2000) · PubMed · Cited by 1,292 · see citing works

Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma

Caldas, C., Hahn, S. A., da Costa, L. T., Redston, M. S., Schutte, M. E. M., Seymour, A. B., Weinstein, C. L., Hruban, R. H., Yeo, C. J., & Kern, S. E. (1994) · Nature Genetics · doi:10.1038/ng0994-27 · Cited by 1,132 · see citing works

Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer

Arumugam, T., Ramachandran, V., Fournier, K. F., Wang, H., Marquis, L., Abbruzzese, J. L., Gallick, G. E., Logsdon, C. D., McConkey, D. J., & Choi, W. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2819 · Cited by 866 · see citing works

DPC4 gene in various tumor types.

Schutte, M. E. M., Hruban, R. H., Hedrick, L., Cho, K. R., Nadasdy, G. M., Weinstein, C. L., Bova, G. S., Isaacs, W. B., Cairns, P., Nawroz, H., et al. (1996) · PubMed · Cited by 672 · see citing works

Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas.

Schutte, M. E. M., Hruban, R. H., Geradts, J., Maynard, R. D., Hilgers, W., Rabindran, S. K., Moskaluk, C. A., Hahn, S. A., Schwarte‐Waldhoff, I., Schmiegel, W., et al. (1997) · PubMed · Cited by 659 · see citing works

Establishment of a continuous tumor‐cell line (PANC‐1) from a human carcinoma of the exocrine pancreas

Lieber, M. M., Mazzetta, J., Nelson‐Rees, W. A., Kaplan, M. J., & Todaro, G. J. (1975) · International Journal of Cancer · doi:10.1002/ijc.2910150505 · Cited by 509 · see citing works

Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray

Maitra, A., Adsay, N. V., Argani, P., Iacobuzio-Donahue, C., De Marzo, A., Cameron, J. L., Yeo, C. J., & Hruban, R. H. (2003) · Modern Pathology · doi:10.1097/01.mp.0000086072.56290.fb · Cited by 429 · see citing works

Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs.

Molina, M. A., Sitjà, M., Lemoine, M. G., et al. (1999) · PubMed · Cited by 406 · see citing works

Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice.

Arenberg, D. A., Kunkel, S. L., Polverini, P. J., Glass, M., Burdick, M. D., & Strieter, R. M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118734 · Cited by 401 · see citing works

High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma

Seo, Y., Baba, H., Fukuda, T., Takashima, M., & Sugimachi, K. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000515)88:10 · Cited by 400 · see citing works

Human pancreatic carcinoma (mia paca‐2) in continuous culture: Sensitivity to asparaginase

Yunis, A. A., Arimura, G. K., & Russin, D. J. (1977) · International Journal of Cancer · doi:10.1002/ijc.2910190118 · Cited by 373 · see citing works

PGE2 and Angiogenesis

Form, D. M., & Auerbach, R. (1983) · Experimental Biology and Medicine · doi:10.3181/00379727-172-41548 · Cited by 342 · see citing works

Increased Survival, Proliferation, and Migration in Metastatic Human Pancreatic Tumor Cells Expressing Functional CXCR4

Marchesi, F., Monti, P., Leone, B. E., Zerbi, A., Vecchi, A., Piemonti, L., Mantovani, A., & Allavena, P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1343 · Cited by 335 · see citing works

Genetic profile of 22 pancreatic carcinoma cell lines: Analysis of K-ras, p53, p16 and DPC4/Smad4

Moore, P. S., Sipos, B., Orlandini, S., Sorio, C., Real, F. X., Lemoine, N. R., Gress, T., Bassi, C., Klöppel, G., Kalthoff, H., et al. (2001) · Virchows Archiv · doi:10.1007/s004280100474 · Cited by 329 · see citing works

The Influence of Culture Time and Passage Number on the Morphological and Physiological Development of Caco-2 Cells

Briske‐Anderson, M., Finley, J. W., & Newman, S. M. (1997) · Experimental Biology and Medicine · doi:10.3181/00379727-214-44093 · Cited by 317 · see citing works

Prognostic significance of angiogenesis in human pancreatic cancer

Ikeda, N., Adachi, M., Taki, T., Huang, C., Hashida, H., Takabayashi, A., Sho, M., Nakajima, Y., Kanehiro, H., Hisanaga, M., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690248 · Cited by 315 · see citing works

A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform

Sipos, B., Möser, S., Kalthoff, H., Török, V., Löhr, M. J., & Klöppel, G. (2003) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-003-0784-4 · Cited by 309 · see citing works

Cyclooxygenase-2 expression in human pancreatic adenocarcinomas

YIP-SCHNEIDER, M. T. (2000) · Carcinogenesis · doi:10.1093/carcin/21.2.139 · Cited by 293 · see citing works

Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression.

Itakura, J., Ishiwata, T., Friess, H., Fujii, H., Matsumoto, Y., Büchler, M. W., & Korc, M. (1997) · PubMed · Cited by 268 · see citing works

Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies.

Metzgar, R. S., Gaillard, M. T., Levine, S. J., Tuck, F. L., Bossen, E. H., & Borowitz, M. J. (1982) · PubMed · Cited by 246 · see citing works

Morphology of angiogenesis in human cancer: a conceptual overview, histoprognostic perspective and significance of neoangiogenesis

Sharma, S., Sharma, M. C., & Sarkar, C. (2005) · Histopathology · doi:10.1111/j.1365-2559.2005.02142.x · Cited by 244 · see citing works

S100P Promotes Pancreatic Cancer Growth, Survival, and Invasion

Arumugam, T., Simeone, D. M., van Golen, K., & Logsdon, C. D. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0092 · Cited by 243 · see citing works

A cystic fibrosis pancreatic adenocarcinoma cell line.

Schoumacher, R., Ram, J., Iannuzzi, M. C., Bradbury, N. A., Wallace, R. W., Hon, C. T., Kelly, D. R., Schmid, S. M., Gelder, F. B., & Rado, T. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.10.4012 · Cited by 243 · see citing works

Comparative analysis of mutations in the p53 and K‐ras genes in pancreatic cancer

Berrozpe, G., Schaeffer, J., Peinado, M. A., Real, F. X., & Perucho, M. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910580207 · Cited by 236 · see citing works

Characterization of a New Primary Human Pancreatic Tumor Line

Tan, M. H., Nowak, N. J., Loor, R., et al. (1986) · Cancer Investigation · doi:10.3109/07357908609039823 · Cited by 228 · see citing works

Aberrant Methylation of Preproenkephalin and p16 Genes in Pancreatic Intraepithelial Neoplasia and Pancreatic Ductal Adenocarcinoma

Fukushima, N., Sato, N., Ueki, T., Rosty, C., Walter, K., Wilentz, R. E., Yeo, C. J., Hruban, R. H., & Goggins, M. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61104-2 · Cited by 225 · see citing works

Down-regulation of E-cadherin gene expression by collagen type I and type III in pancreatic cancer cell lines.

Menke, A., Philippi, C., Vogelmann, R., Seidel, B., Lutz, M. P., Adler, G., & Wedlich, D. (2001) · PubMed · Cited by 196 · see citing works

Array Comparative Genomic Hybridization Analysis of Colorectal Cancer Cell Lines and Primary Carcinomas

Douglas, E. J., Fiegler, H., Rowan, A., Halford, S. E. R., Bicknell, D., Bodmer, W. F., Tomlinson, I. P. M., & Carter, N. P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0328 · Cited by 192 · see citing works

Multi-scale modeling of a wound-healing cell migration assay

Cai, A. Q., Landman, K. A., & Hughes, B. D. (2006) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2006.10.024 · Cited by 182 · see citing works

Epithelial Cell Cultures From Normal and Cancerous Human Tissues2

Owens, R. B., Smith, H. S., Nelson‐Rees, W. A., & Springer, E. (1976) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/56.4.843 · Cited by 180 · see citing works

Pathways for aberrant angiogenesis in pancreatic cancer.

Korc, M. (2003) · Molecular Cancer · doi:10.1186/1476-4598-2-8 · Cited by 178 · see citing works

Orthotopic Transplantation Models of Pancreatic Adenocarcinoma Derived From Cell Lines and Primary Tumors and Displaying Varying Metastatic Activity

Loukopoulos, P., Kanetaka, K., Takamura, M., Shibata, T., Sakamoto, M., & Hirohashi, S. (2004) · Pancreas · doi:10.1097/00006676-200410000-00004 · Cited by 172 · see citing works

Expression of two angiogenic factors, vascular endothelial growth factor and platelet-derived endothelial cell growth factor in human pancreatic cancer, and its relationship to angiogenesis

Fujimoto, K., Hosotani, R., Wada, M., et al. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00069-0 · Cited by 168 · see citing works

Human pancreatic adenocarcinoma: In vitro and in vivo morphology of a new tumor line established from ascites

Chen, W. H., Horoszewicz, J. S., Leong, S. S., Shimano, T., Penetrante, R. B., Sanders, W. H., Berjian, R. A., Douglass, H. O., Martin, E. W., & Chu, T. M. (1982) · In Vitro Cellular & Developmental Biology - Plant · doi:10.1007/bf02796382 · Cited by 163 · see citing works

Vessel counts and vascular endothelial growth factor expression in pancreatic adenocarcinoma

Ellis, L. M., Takahashi, Y., Fenoglio, C. J., et al. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(97)10068-5 · Cited by 160 · see citing works

The genetics of pancreatic cancer

Cowgill, S. M., & Muscarella, P. (2003) · The American Journal of Surgery · doi:10.1016/s0002-9610(03)00226-5 · Cited by 156 · see citing works

Lipoxygenase and cyclooxygenase metabolism: new insights in treatment and chemoprevention of pancreatic cancer.

Ding, X., Hennig, R., & Adrian, T. E. (2003) · Molecular Cancer · doi:10.1186/1476-4598-2-10 · Cited by 151 · see citing works

Mechanisms in LPA-induced tumor cell migration: critical role of phosphorylated ERK

Stähle, M., Veit, C., Bachfischer, U., Schierling, K., Skripczynski, B., Hall, A., Gierschik, P., & Giehl, K. (2003) · Journal of Cell Science · doi:10.1242/jcs.00679 · Cited by 148 · see citing works

Persistence of microscopic human cancers in mice: alterations in the angiogenic balance accompanies loss of tumor dormancy

Udagawa, T., Fernández, A., Achilles, E., Folkman, J., & D’Amato, R. J. (2002) · The FASEB Journal · doi:10.1096/fj.01-0813com · Cited by 147 · see citing works

TGF-?-induced invasiveness of pancreatic cancer cells is mediated by matrix metalloproteinase-2 and the urokinase plasminogen activator system

Ellenrieder, V., Hendler, S. F., Ruhland, C., Boeck, W., Adler, G., & Gress, T. M. (2001) · International Journal of Cancer · doi:10.1002/ijc.1330 · Cited by 146 · see citing works

Expression of interleukin-8 receptors on tumor cells and vascular endothelial cells in human breast cancer tissue.

MILLER, L. J., Kurtzman, S. H., Wang, Y., Anderson, K. H., Lindquist, R. R., & Kreutzer, D. L. (1998) · PubMed · Cited by 141 · see citing works

Activation of focal adhesion kinase enhances the adhesion and invasion of pancreatic cancer cells via extracellular signal-regulated kinase-1/2 signaling pathway activation

Sawai, H., Okada, Y., Funahashi, H., et al. (2005) · Molecular Cancer · doi:10.1186/1476-4598-4-37 · Cited by 139 · see citing works

Diet and brain cancer in adults: A case-control study in Northeast China

Hu, J., Vecchia, C. L., Negri, E., Chatenoud, L., Bosetti, C., Jia, X., Liu, R., Huang, G., Bi, D., & Wang, C. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990331)81:1 · Cited by 136 · see citing works

Evidence for Diminished Functional Expression of Intestinal Transporters in Caco-2 Cell Monolayers at High Passages

Yu, H., Cook, T. J., & Sinko, P. J. (1997) · Pharmaceutical Research · doi:10.1023/a:1012150405949 · Cited by 133 · see citing works

High-Resolution Genomic and Expression Profiling Reveals 105 Putative Amplification Target Genes in Pancreatic Cancer

Mahlamäki, E., Kauraniemi, P., Monni, O. M., Wolf, M., Hautaniemi, S., & Kallioniemi, A. H. (2004) · Neoplasia · doi:10.1593/neo.04130 · Cited by 128 · see citing works

Angiogenesis: the role of the microenvironment in flipping the switch

Giordano, F. J., & Johnson, R. S. (2001) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00153-2 · Cited by 128 · see citing works

Duct changes and K-ras mutations in the disease-free pancreas: analysis of type, age relation and spatial distribution

Lüttges, J., Reinecke-Lüthge, A., Möllmann, B., Menke, M. A. O. H., Clemens, A., Klimpfinger, M., Sipos, B., & Klöppel, G. (1999) · Virchows Archiv · doi:10.1007/s004280050428 · Cited by 127 · see citing works

HIF-1alpha-mediated up-regulation of vascular endothelial growth factor, independent of basic fibroblast growth factor, is important in the switch to the angiogenic phenotype during early tumorigenesis.

Fang, J., Li, Y., Shing, Y., & Moses, M. A. (2001) · PubMed · Cited by 125 · see citing works

Cystic fibrosis transmembrane regulator ( CFTR ) ΔF508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreatic cancer

Malats, N., Casals, T., Porta, M. S., et al. (2001) · Gut · doi:10.1136/gut.48.1.70 · Cited by 125 · see citing works

Vascular Endothelial Growth Factor-Trap Suppresses Tumorigenicity of Multiple Pancreatic Cancer Cell Lines

Fukasawa, M., & Korc, M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0820 · Cited by 122 · see citing works

PGE2 is generated by specific COX-2 activity and increases VEGF production in COX-2-expressing human pancreatic cancer cells

Eibl, G., Bruemmer, D., Okada, Y., et al. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01079-9 · Cited by 122 · see citing works

Genetic alterations in pancreatic carcinoma.

Schneider, G., & Schmid, R. M. (2003) · Molecular Cancer · doi:10.1186/1476-4598-2-15 · Cited by 121 · see citing works

Human pancreatic adenocarcinoma line Capan-1 in tissue culture and the nude mouse: morphologic, biologic, and biochemical characteristics.

Kyriazis, A. P., Kyriazis, A. A., Scarpelli, D. G., et al. (1982) · PubMed · Cited by 119 · see citing works

LNCaP prostatic adenocarcinoma cells derived from low and high passage numbers display divergent responses not only to androgens but also to retinoids

Esquenet, M., Swinnen, J. V., Heyns, W., & Verhoeven, G. (1997) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)00054-x · Cited by 115 · see citing works

Leukotriene B4 receptor antagonist LY293111 inhibits proliferation and induces apoptosis in human pancreatic cancer cells.

Tong, W., Ding, X., Hennig, R., Witt, R. C., Standop, J., Pour, P. M., & Adrian, T. E. (2002) · PubMed · Cited by 114 · see citing works

Effect of passage number on cellular response to DNA-damaging agents: cell survival and gene expression

Chang‐Liu, C., & Woloschak, G. E. (1997) · Cancer Letters · doi:10.1016/s0304-3835(97)04599-0 · Cited by 102 · see citing works

sst2 somatostatin receptor expression reverses tumorigenicity of human pancreatic cancer cells.

Delesque, N., Buscail, L., Estève, J. P., et al. (1997) · PubMed · Cited by 102 · see citing works

Cell Cycle Effects of Nonsteroidal Anti-Inflammatory Drugs and Enhanced Growth Inhibition in Combination with Gemcitabine in Pancreatic Carcinoma Cells

Yip-Schneider, M., Sweeney, C. J., Jung, S., Crowell, P. L., & Marshall, M. S. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29465-9 · Cited by 100 · see citing works

Pancreatic cancer cell-derived vascular endothelial growth factor is biologically activein vitro and enhances tumorigenicityin vivo

Luo, J., Guo, P., Matsuda, K., Truong, N., Lee, A., Chun, C. L., Cheng, S., & Korc, M. (2001) · International Journal of Cancer · doi:10.1002/ijc.1202 · Cited by 93 · see citing works

Regulation of pancreatic cancer cell migration and invasion by RhoC GTPase and Caveolin-1

Lin, M. T., DiVito, M. M., Merajver, S. D., et al. (2005) · Molecular Cancer · doi:10.1186/1476-4598-4-21 · Cited by 93 · see citing works

An Orthotopic Nude Mouse Model for Evaluating Pathophysiology and Therapy of Pancreatic Cancer

Hotz, H. G., Reber, H. A., Hotz, B., et al. (2003) · Pancreas · doi:10.1097/00006676-200305000-00020 · Cited by 90 · see citing works

Characterization of the mutations of the K-ras, p53, p16, and SMAD4 genes in 15 human pancreatic cancer cell lines.

Sun, C., Yamato, T., Furukawa, T., Ohnishi, Y., Kijima, H., & Horii, A. (2001) · Oncology Reports · doi:10.3892/or.8.1.89 · Cited by 89 · see citing works

Effect of culture conditions on androgen sensitivity of the human prostatic cancer cell line LNCaP

Langeler, E. G., van Uffelen, C. J. C., Blankenstein, M. A., van Steenbrugge, G. J., & Mulder, E. (1993) · The Prostate · doi:10.1002/pros.2990230304 · Cited by 89 · see citing works

Cyclooxygenase-2-dependent and -independent effects of celecoxib in pancreatic cancer cell lines

El-Rayes, B. F., Ali, S. S., Sarkar, F. H., et al. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1421.3.11 · Cited by 87 · see citing works

Deletion and mutation analyses of the P16/MTS-1 tumor suppressor gene in human ductal pancreatic cancer reveals a higher frequency of abnormalities in tumor-derived cell lines than in primary ductal adenocarcinomas.

Huang, L., Goodrow, T. L., Zhang, S. Y., Klein-Szanto, A. J., Chang, H., & Ruggeri, B. (1996) · PubMed · Cited by 86 · see citing works

The Trk tyrosine kinase inhibitor CEP-701 (KT-5555) exhibits significant antitumor efficacy in preclinical xenograft models of human pancreatic ductal adenocarcinoma.

Miknyoczki, S. J., Chang, H., Klein–Szanto, A. J., et al. (1999) · PubMed · Cited by 83 · see citing works

Expression and Activity of Src Regulate Interleukin-8 Expression in Pancreatic Adenocarcinoma Cells: Implications for Angiogenesis

Trevino, J. G., Summy, J. M., Gray, M. J., Nilsson, M. B., Lesslie, D. P., Baker, C. H., & Gallick, G. E. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3858 · Cited by 83 · see citing works

Gene Expression Profile of Metastatic Human Pancreatic Cancer Cells Depends on the Organ Microenvironment

Nakamura, T., Fidler, I. J., & Coombes, K. R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2563 · Cited by 83 · see citing works

Genetic abnormalities in pancreatic cancer.

Moore, P. S., Beghelli, S., Zamboni, G., & Scarpa, A. (2003) · Molecular Cancer · doi:10.1186/1476-4598-2-7 · Cited by 80 · see citing works

Expression and Function of Receptors for Extracellular Matrix Proteins in Human Ductal Adenocarcinomas of the Pancreas

Löhr, M. J., Trautmann, B., Göttler, M., et al. (1996) · Pancreas · doi:10.1097/00006676-199604000-00007 · Cited by 79 · see citing works

Smad4/DPC4-dependent Regulation of Biglycan Gene Expression by Transforming Growth Factor-β in Pancreatic Tumor Cells

Chen, W., Lenschow, W., Tiede, K., Fischer, J. W., Kalthoff, H., & Ungefroren, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203709200 · Cited by 79 · see citing works

Comparative Genomic Hybridization Reveals Complex Genetic Changes in Primary Breast Cancer Tumors and Their Cell Lines

Larramendy, M. L., Lushnikova, T., Björkqvist, A., Wistuba, I. I., Virmani, A. K., Shivapurkar, N., Gazdar, A. F., & Knuutila, S. (2000) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(99)00226-5 · Cited by 77 · see citing works

Tissue plasminogen activator is required for the growth, invasion, and angiogenesis of pancreatic tumor cells

Diaz, V. M., Planagumà, J., Thomson, T. M., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.31885 · Cited by 74 · see citing works

Suppression of Human Pancreatic Carcinoma Cell Growth and Invasion by Epigallocatechin-3-Gallate

Takada, M., Nakamura, Y., Koizumi, T., Toyama, H., Kamigaki, T., Suzuki, Y., Takeyama, Y., & Kuroda, Y. (2002) · Pancreas · doi:10.1097/00006676-200207000-00012 · Cited by 68 · see citing works

Lack of elevated MAP kinase (Erk) activity in pancreatic carcinomas despite oncogenic K-ras expression.

Yip-Schneider, M., Lin, A., Barnard, D., Sweeney, C. J., & Marshall, M. S. (1999) · International Journal of Oncology · doi:10.3892/ijo.15.2.271 · Cited by 67 · see citing works

??1 Integrins Play an Essential Role in Adhesion and Invasion of Pancreatic Carcinoma Cells

Arao, S., Masumoto, A., & Otsuki, M. (2000) · Pancreas · doi:10.1097/00006676-200003000-00004 · Cited by 64 · see citing works

A comprehensive in vitro characterization of pancreatic ductal carcinoma cell line biological behavior and its correlation with the structural and genetic profile

Monti, P., Marchesi, F., Reni, M., Mercalli, A., Sordi, V., Zerbi, A., Balzano, G., Carlo, V. D., Allavena, P., & Piemonti, L. (2004) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-004-1053-x · Cited by 64 · see citing works

Mutations of the CFTR Gene in Pancreatic Disease

Pezzilli, R., Morselli‐Labate, A. M., Mantovani, V., et al. (2003) · Pancreas · doi:10.1097/00006676-200311000-00011 · Cited by 64 · see citing works

Cystic fibrosis transmembrane regulator gene carrier status is a risk factor for young onset pancreatic adenocarcinoma: Table 1

McWilliams, R. R., Highsmith, W. E., Rabe, K. G., et al. (2005) · Gut · doi:10.1136/gut.2005.074534 · Cited by 62 · see citing works

Celecoxib inhibits angiogenesis by inducing endothelial cell apoptosis in human pancreatic tumor xenografts

Raut, C. P., Nawrocki, S. T., Lashinger, L. M., et al. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.12.1221 · Cited by 61 · see citing works

Laminin gamma2-chain fragment in the circulation: a prognostic indicator of epithelial tumor invasion.

Katayama, M., Sanzen, N., Funakoshi, A., et al. (2003) · PubMed · Cited by 61 · see citing works

Alterations of tumor suppressor gene p16 INK4a in pancreatic ductal carcinoma

Attri, J., Srinivasan, R., Majumdar, S., Radotra, B. D., & Wig, J. D. (2005) · BMC Gastroenterology · doi:10.1186/1471-230x-5-22 · Cited by 60 · see citing works

The Selective Cyclooxygenase-2 Inhibitor Nimesulide Induces Apoptosis in Pancreatic Cancer Cells Independent of COX-2

Eibl, G., Reber, H. A., Wente, M. N., et al. (2003) · Pancreas · doi:10.1097/00006676-200301000-00007 · Cited by 60 · see citing works

Increased tumorigenicity in the human pancreatic cell line MIA PaCa‐2 Is associated with an aberrant regulation of an IGF‐1 autocrine loop and lack of expression of the TGF‐β type RII receptor

Freeman, J. W., Mattingly, C. A., & Strodel, W. E. (1995) · Journal of Cellular Physiology · doi:10.1002/jcp.1041650118 · Cited by 59 · see citing works

VEGF antisense therapy inhibits tumor growth and improves survival in experimental pancreatic cancer

Hotz, H. G., Hines, O. J., Masood, R., et al. (2005) · Surgery · doi:10.1016/j.surg.2004.07.015 · Cited by 59 · see citing works

Enhanced Angiogenesis Due to Inflammatory Cytokines from Pancreatic Cancer Cell Lines and Relation to Metastatic Potential

Matsuo, Y., Sawai, H., Funahashi, H., Takahashi, H., Sakamoto, M., Yamamoto, M., Okada, Y., Hayakawa, T., & Manabe, T. (2004) · Pancreas · doi:10.1097/00006676-200404000-00025 · Cited by 58 · see citing works

Pancreatic Resection Combined With Intraoperative Radiation Therapy for Pancreatic Cancer

Farrell, T. J., Barbot, D. J., & Rosato, F. E. (1997) · Annals of Surgery · doi:10.1097/00000658-199707000-00009 · Cited by 55 · see citing works

In Vitro Properties of Epithelial Cell Lines Established from Human Carcinomas and Nonmalignant Tissue 2

Smith, H. S. (1979) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/62.2.225 · Cited by 55 · see citing works

Morphological, biological, biochemical, and karyotypic characteristics of human pancreatic ductal adenocarcinoma Capan-2 in tissue culture and the nude mouse.

Kyriazis, A. A., Kyriazis, A. P., Sternberg, C. N., et al. (1986) · PubMed · Cited by 53 · see citing works

A Xenograft Nude Mouse Model for Perineural Invasion and Recurrence in Pancreatic Cancer

Eibl, G., & Reber, H. A. (2005) · Pancreas · doi:10.1097/01.mpa.0000175176.40045.0f · Cited by 52 · see citing works

HPAC, a new human glucocorticoid-sensitive pancreatic ductal adenocarcinoma cell line

Gower, W. R., Risch, R. M., Godellas, C. V., et al. (1994) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/bf02631438 · Cited by 51 · see citing works

Characterization of mutations and loss of heterozygosity of p53 and K-ras2 in pancreatic cancer cell lines by immobilized polymerase chain reaction

Butz, J. A., Wickstrom, E., & Edwards, J. S. (2003) · BMC Biotechnology · doi:10.1186/1472-6750-3-11 · Cited by 44 · see citing works

p16INK4a alterations in chronic pancreatitis—indicator for high-risk lesions for pancreatic cancer

Gerdes, B., Ramaswamy, A., Kersting, M., Ernst, M. E., Lang, S. A., Schuermann, M., Wild, A., & Bartsch, D. K. (2001) · Surgery · doi:10.1067/msy.2001.112071 · Cited by 37 · see citing works

Alteration of Integrins by Interleukin-1α in Human Pancreatic Cancer Cells

Sawai, H., Yamamoto, M., Okada, Y., et al. (2001) · Pancreas · doi:10.1097/00006676-200111000-00011 · Cited by 36 · see citing works

Pancreatic Cancer Cells Invasiveness is Mainly Affected by Interleukin-1β not by Transforming Growth Factor-β1

Greco, E., Basso, D., Fogar, P., et al. (2005) · The International Journal of Biological Markers · doi:10.1177/172460080502000406 · Cited by 35 · see citing works

A new human pancreatic carcinoma cell line developed for adoptive immunotherapy studies with lymphokine-activated killer cells in nude mice

Drucker, B. J., Marincola, F. M., Siao, D. Y., Donlon, T. A., Bangs, C. D., & Holder, W. D. (1988) · In Vitro Cellular & Developmental Biology - Plant · doi:10.1007/bf02624187 · Cited by 31 · see citing works

Influence of p53 status on radiation and 5-flourouracil synergy in pancreatic cancer cells.

Mohiuddin, M., Damodaran, C., Dey, S., et al. (2002) · PubMed · Cited by 31 · see citing works

Alteration of Integrin Expression by Glial Cell Line-Derived Neurotrophic Factor (GDNF) in Human Pancreatic Cancer Cells

Funahashi, H., Takeyama, H., Sawai, H., Furuta, A., Sato, M., Okada, Y., Hayakawa, T., Tanaka, M., & Manabe, T. (2003) · Pancreas · doi:10.1097/00006676-200308000-00013 · Cited by 29 · see citing works

Effects of sodium butyrate and dimethylsulfoxide on human pancreatic tumor cell lines

McIntyre, L. J., & Kim, Y. S. (1984) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(84)90194-9 · Cited by 28 · see citing works

Selective Blockade of Vascular Endothelial Growth Factor Receptor 2 With an Antibody Against Tumor-Derived Vascular Endothelial Growth Factor Controls the Growth of Human Pancreatic Adenocarcinoma Xenografts

Holloway, S. E., Beck, A. W., Shivakumar, L., et al. (2006) · Annals of Surgical Oncology · doi:10.1245/aso.2006.05.049 · Cited by 28 · see citing works

Role of target antigen in bispecific-antibody-mediated killing of human glioblastoma cells: A pre-clinical study

Pfosser, A., Brandl, M., Salih, H., Große‐Hovest, L., & Jung, G. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990209)80:4 · Cited by 27 · see citing works

Suicide gene therapy with HSV-TK in pancreatic cancer has no effect in vivo in a mouse model

Fogar, P., Greco, E., Basso, D., et al. (2003) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2003.08.001 · Cited by 27 · see citing works

Cytokines Modulate MIA PaCa 2 and CAPAN-1 Adhesion to Extracellular Matrix Proteins

Stefani, A. L., Basso, D., Panozzo, M., et al. (1999) · Pancreas · doi:10.1097/00006676-199911000-00007 · Cited by 27 · see citing works

Epidermal growth factor mediates detachment from and invasion through collagen I and Matrigel in Capan-1 pancreatic cancer cells

Shirk, A. J., & Kuver, R. P. (2005) · BMC Gastroenterology · doi:10.1186/1471-230x-5-12 · Cited by 26 · see citing works

Potential involvement of the cyclooxygenase-2 pathway in the regulation of tumor-associated angiogenesis and growth in pancreatic cancer.

Chu, J., Lloyd, F. L., Trifan, O. C., et al. (2003) · PubMed · Cited by 25 · see citing works

Antioxidants Inhibit Cytokine Production and Suppress NF-κB Activation in CAPAN-1 and CAPAN-2 Cell Lines

Blanchard, J. A., Barve, S. S., Joshi‐Barve, S., et al. (2001) · Digestive Diseases and Sciences · doi:10.1023/a:1012795900871 · Cited by 23 · see citing works

Pancreatic Cancer - New Aspects of Molecular Biology Research

Kleeff, J. H., Friess, Berberat, P. O., et al. (2000) · Swiss Surgery · doi:10.1024/1023-9332.6.5.231 · Cited by 23 · see citing works

Selective Inhibition of Endothelin Receptor A as an Anti-angiogenic and Anti-proliferative Strategy for Human Pancreatic Cancer

Bhargava, S., Stummeyer, T., Hotz, B., et al. (2005) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2004.11.007 · Cited by 19 · see citing works

A quinolinone derivative, vesnarinone (OPC-8212), significantly inhibits the in vitro and in vivo growth of human pancreatic cancer cell lines

Nio, Y., Ohmori, H., Minari, Y., Hirahara, N., Sasaki, S., Takamura, M., & Tamura, K. (1997) · Anti-Cancer Drugs · doi:10.1097/00001813-199708000-00007 · Cited by 16 · see citing works

Reassessment of K-ras Mutations at Codon 12 by Direct PCR and Sequencing from Tissue Microdissection in Human Pancreatic Adenocarcinomas

Aoki, Y., Hosaka, S., Tachibana, N., et al. (2000) · Pancreas · doi:10.1097/00006676-200008000-00008 · Cited by 14 · see citing works

Natural History of Pancreatic Cancer Recurrence Following “Curative” Resection in Athymic Mice

Torgenson, M., Shea, J., Firpo, M. A., et al. (2007) · Journal of Surgical Research · doi:10.1016/j.jss.2007.08.024 · Cited by 13 · see citing works

Decrease of human pancreatic cancer cell tumorigenicity by α1,3galactosyltransferase gene transfer

Aubert, M., Crotte, C., Bernard, J., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.11470 · Cited by 10 · see citing works

Attachment of human pancreatic tumor cell lines to collagen in vitro.

McIntyre, L. J., Kleinman, H. K., Martin, G. R., et al. (1981) · PubMed · Cited by 9 · see citing works

CD44v10: An antimetastatic membrane glycoprotein for pancreatic cancer

Navaglia, F., Fogar, P., Greco, E., et al. (2003) · The International Journal of Biological Markers · doi:10.5301/jbm.2008.4459 · Cited by 6 · see citing works

Multicellular spheroid based on a triple co-culture: A novel 3D model to mimic pancreatic tumor complexity

Lazzari, G., Nicolas, V., Matsusaki, M., Akashi, M., Couvreur, P., & Mura, S. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.08.008 · Cited by 271 · see citing works

Screening for Pancreatic Cancer: Why, How, and Who?

Poruk, K. E., Firpo, M. A., Adler, D. G., & Mulvihill, S. J. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e31825ffbfb · Cited by 249 · see citing works

CSF1R(+) macrophages sustain pancreatic tumor growth through T cell suppression and maintenance of key gene programs that define the squamous subtype

Candido, J. B., Morton, J. P., Bailey, P., Campbell, A. D., Karim, S. A., Jamieson, T., Lapienyte, L., Gopinathan, A., Clark, W., McGhee, E. J., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.131 · Cited by 224 · see citing works

Molecular mechanism for USP7-mediated DNMT1 stabilization by acetylation.

Cheng, J., Yang, H., Fang, J., Ma, L., Gong, R., Wang, P., Li, Z., & Xu, Y. (2015) · Nature Communications · doi:10.1038/ncomms8023 · Cited by 158 · see citing works

Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer

Stefanoudakis, D., Frountzas, M., Schizas, D., Michalopoulos, N. V., Drakaki, A., & Toutouzas, K. G. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46040177 · Cited by 110 · see citing works

Patient-derived xenograft models of pancreatic cancer: overview and comparison with other types of models

Garcia, P. L., Miller, A. L., & Yoon, K. J. (2020) · Cancers · doi:10.3390/cancers12051327 · Cited by 77 · see citing works

Mutations of p53 associated with pancreatic cancer and therapeutic implications

Voutsadakis, I. A. (2021) · Annals of Hepato-Biliary-Pancreatic Surgery · doi:10.14701/ahbps.2021.25.3.315 · Cited by 75 · see citing works

A novel microfluidic 3D platform for culturing pancreatic ductal adenocarcinoma cells: comparison with in vitro cultures and in vivo xenografts

Beer, M., Kuppalu, N., Stefanini, M., Becker, H., Schulz, I., Manoli, S., Schuette, J., Schmees, C., Casazza, A., Stelzle, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-01256-8 · Cited by 75 · see citing works

Connexin-43 channels are a pathway for discharging lactate from glycolytic pancreatic ductal adenocarcinoma cells

Dovmark, T. H., Saccomano, M., Hulikova, A., Alves, F., & Swietach, P. (2017) · Oncogene · doi:10.1038/onc.2017.71 · Cited by 74 · see citing works

A bioengineered heterotypic stroma–cancer microenvironment model to study pancreatic ductal adenocarcinoma

Drifka, C. R., Eliceiri, K. W., Weber, S. M., & Kao, W. J. (2013) · Lab on a Chip · doi:10.1039/c3lc50487e · Cited by 64 · see citing works

Integrated in silico and 3D in vitro model of macrophage migration in response to physical and chemical factors in the tumor microenvironment

Lee, S. W. L., Seager, R. J., Litvak, F., Spill, F., Sieow, J. L., Leong, P. H., Kumar, D., Tan, A. S. M., Wong, S. C., Adriani, G., et al. (2020) · Integrative Biology · doi:10.1093/intbio/zyaa007 · Cited by 60 · see citing works

Repurposing of Cetuximab in antibody-directed chemotherapy-loaded nanoparticles in EGFR therapy-resistant pancreatic tumours

McDaid, W. J., Greene, M. K., Johnston, M. C., Pollheimer, E., Smyth, P., McLaughlin, K., Van Schaeybroeck, S., Straubinger, R. M., Longley, D. B., & Scott, C. J. (2019) · Nanoscale · doi:10.1039/c9nr07257h · Cited by 58 · see citing works

Pre-clinical Models of Metastasis in Pancreatic Cancer

Miquel, M., Zhang, S., & Pilarsky, C. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.748631 · Cited by 53 · see citing works

CDKN2A-Inactivated Pancreatic Ductal Adenocarcinoma Exhibits Therapeutic Sensitivity to Paclitaxel: A Bioinformatics Study

Lin, J.-C., Liu, T.-P., & Yang, P.-M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9124019 · Cited by 46 · see citing works

Imaging of glucose metabolism by 13C-MRI distinguishes pancreatic cancer subtypes in mice

Kishimoto, S., Brender, J. R., Crooks, D. R., Matsumoto, S., Seki, T., Oshima, N., Merkle, H., Lin, P., Reed, G., Chen, A. P., et al. (2019) · eLife · doi:10.7554/elife.46312 · Cited by 41 · see citing works

A biomimetic tumor model of heterogeneous invasion in pancreatic ductal adenocarcinoma

Bradney, M. J., Venis, S. M., Yang, Y., Konieczny, S. F., & Han, B. (2020) · Small · doi:10.1002/smll.201905500 · Cited by 38 · see citing works

Molecular imaging of the tumor microenvironment reveals the relationship between tumor oxygenation, glucose uptake, and glycolysis in pancreatic ductal adenocarcinoma

Yamamoto, K., Brender, J. R., Seki, T., Kishimoto, S., Oshima, N., Choudhuri, R., Adler, S. S., Jagoda, E. M., Saito, K., Devasahayam, N., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-0928 · Cited by 37 · see citing works

Occult polyclonality of preclinical pancreatic cancer models drives in vitro evolution

Monberg, M. E., Geiger, H., Lee, J. J., Sharma, R., Semaan, A., Bernard, V., Wong, J., Wang, F., Liang, S., Swartzlander, D. B., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31376-3 · Cited by 30 · see citing works

SRC kinase drives multidrug resistance induced by KRAS-G12C inhibition

Song, X., Zhou, Z., Elmezayen, A., Wu, R., Yu, C., Gao, B., Minna, J. D., Westover, K. D., Zeh, H. J., Kroemer, G., et al. (2024) · Science Advances · doi:10.1126/sciadv.adq4274 · Cited by 26 · see citing works

Wild type and gain of function mutant TP53 can regulate the sensitivity of pancreatic cancer cells to chemotherapeutic drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1/GSK-3 pathway inhibitors, nutraceuticals and alter metabolic properties

McCubrey, J. A., Meher, A. K., Akula, S. M., Abrams, S. L., Steelman, L. S., LaHair, M. M., Franklin, R. A., Martelli, A. M., Ratti, S., Cocco, L., et al. (2022) · Aging · doi:10.18632/aging.204038 · Cited by 12 · see citing works

Machine learning improves classification of preclinical models of pancreatic cancer with chemical exchange saturation transfer MRI

Goldenberg, J. M., Cárdenas‐Rodríguez, J., & Pagel, M. D. (2019) · Magnetic Resonance in Medicine · doi:10.1002/mrm.27439 · Cited by 10 · see citing works